Staurosporine

星孢菌素

Report date: 2022/08/29 15:00:50

Base Information

Drug NameStaurosporine
Drug Alias Name星形孢菌素AM-2282
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of ActionPlatelet aggregation inhibitorsProtein kinase C inhibitors
TargetsProtein kinase C
Therapy Area/IndicationsHypertensionThrombosisArrhythmias, Cardiac +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAsahi Kasei Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsahi Kasei Corp
Active IndicationsN/A
Inactive IndicationsHypertensionThrombosisArrhythmias, Cardiac +[4] 

Other Information

ATC CodeN/A
Related LinksN/A